Calithera Biosciences (CALA) PT Raised to $17 at JMP Securities Following Recent Developments with CB-839 & CB-1158
Tweet Send to a Friend
JMP Securities analyst Michael King raised its price target on Calithera Biosciences (NASDAQ: CALA) to $17.00 (from $12.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
